(Q34177433)

31 July 2017

1 reference

title

The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae (English)

1 reference

31 July 2017

1 reference

Isaac Ginsburg

1

1 reference

31 July 2017

publication date

1 November 2002

1 reference

Acta Pathologica et Microbiologica Scandinavica

31 July 2017

published in

1 reference

31 July 2017

volume

110

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

753-770

1 reference

Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Antibiotic-induced release of endotoxin: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

The effect of leukocyte hydrolases on bacteria. III. Bacteriolysis induced by extracts of different leukocyte populations and the inhibition of lysis by macromolecular substances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Triggering of Pneumococcal Autolysis by Lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Transglycosylase and endopeptidase participate in the degradation of murein during autolysis of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Subcellular distribution of the soluble lytic transglycosylase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

From Penicillin-Binding Proteins to the Lysis and Death of Bacteria: A 1979 View

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

[Mechanisms of resistance to beta-lactam antibiotics].

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Penicillin-binding protein-mediated resistance in pneumococci and staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Protection by D-amino acids against growth inhibition and lysis caused by beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

Cell damage in inflammatory and infectious sites might involve a coordinated "cross-talk" among oxidants, microbial haemolysins and ampiphiles, cationic proteins, phospholipases, fatty acids, proteinases and cytokines (an overview).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Could synergistic interactions among reactive oxygen species, proteinases, membrane-perforating enzymes, hydrolases, microbial hemolysins and cytokines be the main cause of tissue damage in infectious and inflammatory conditions?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Can we learn from the pathogenetic strategies of group A hemolytic streptococci how tissues are injured and organs fail in post-infectious and inflammatory sequelae?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Issues in the adjunct therapy of severe sepsis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Clinical trials in sepsis: where do we stand?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Therapy of sepsis: why have we made such little progress?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Why immunomodulatory therapies have not worked in sepsis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Immunomodulatory therapies in sepsis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The detection and interpretation of endotoxaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Clinical trials of mediator-directed therapy in sepsis: what have we learned?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Cationic polyelectrolytes: a new look at their possible roles as opsonins, as stimulators of respiratory burst in leukocytes, in bacteriolysis, and as modulators of immune-complex diseases (a review hypothesis).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Role of lipoteichoic acid in infection and inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bacteriolytic and bactericidal activity of maternal and cord sera. Relationship to complement, lysozyme, transferrin, and immunoglobulin levels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bacterial walls, peptidoglycan hydrolases, autolysins, and autolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

On a Remarkable Bacteriolytic Element Found in Tissues and Secretions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The inflammatory basis of trauma/shock-associated multiple organ failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The interaction of leukocytes and their hydrolases with bacteria in vitro and in vivo: the modification of the bactericidal and bacteriolytic reactions by cationic and anionic macromolecular substances and by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Lysis and biodegradation of microorganisms in infectious sites may involve cooperation between leukocyte, serum factors and bacterial wall autolysins: a working hypothesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bacterial products as immunomodulating agents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The Effect of Leukocyte Hydrolases on Bacteria. XI. Lysis by Leukocyte Extracts and by Myeloperoxidase of a Staphylococcus aureus Mutant Which is Deficient in Teichoic Acid, and the Inhibition of Bacteriolysis by Lipoteichoic Acid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effect of leukocyte hydrolases on bacteria. IX. The release of lipoteichoic acid from group A streptococci and from Strep. mutans by leukocyte extracts and by lysozyme: relation to tissue damage in inflammatory sites

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The effect of leukocyte hydrolases on bacteria : IV. The role played by artificial enzyme "cocktails" and tissue enzymes in bacteriolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effect of leukocyte hydrolases on bacteria. XIII. Role played by leukocyte extracts, lysolecithin, phospholipase a2, lysozyme, cationic proteins, and detergents in the solubilization of lipids from Staphylococcus aureus and group A streptococci: rel

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Properties of the cell surfaces of pathogenic bacteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effect of Leukocyte Hydrolases on Bacteria. I. Degradation of 14C-Labeled Streptococcus and Staphylococcus by Leukocyte Lysates in Vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The effect of leukocyte hydrolases on bacteria. II. The synergistic action of lysozyme and extracts of PMN, macrophages, lymphocytes, and platelets in bacteriolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The effect of leukocyte hydrolases on bacteria VIII. The combined effect of leukocyte extracts, lysozyme, enzyme "cocktails," and penicillin on the lysis ofStaphylococcus aureus and group a streptococci in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Cell wall degradation of Staphylococcus aureus by lysozyme

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The effect of leukocyte hydrolases on bacteria. XII. The release of lipopolysaccharide (LPS) from Salmonella typhi by leukocyte extracts, lysozyme, inflammatory exudates and by serum and synovial fluid and the modulation by anionic and cationic poly

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The effect of leukocyte hydrolases on bacteria : V. Modification of bacteriolysis by antiinflammatory agents and by cationic and anionic polyelectrolytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effect of leukocyte hydrolases on bacteria. X. The role played by leukocyte factors, cationic polyelectrolytes, and by membrane-damaging agents in the lysis of Staphylococcus aureus: relation to chronic inflammatory processes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Induction of autolysis in Enterococcus faecalis S-47 by peptide AS-48

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Elucidation of the antistaphylococcal action of lactoferrin and lysozyme

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Cationic proteins of polymorphonuclear leukocyte lysosomes. II. Composition, properties, and mechanism of antibacterial action

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bactericidal and bacteriolytic immune reactions. Respective roles of complement and lysozyme. Their value in defense mechanisms against infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The mechanism by which microorganisms avoid complement attack

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effect of divalent cations on permeabilizer-induced lysozyme lysis of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Degradation of gonococcal peptidoglycan by granule extract from human neutrophils: demonstration of N-acetylglucosaminidase activity that utilizes peptidoglycan substrates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Mode of Action of -Lactam Antibiotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

1 reference

7 January 2021

Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Basic mechanisms of bacterial tolerance of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Mechanisms of methicillin resistance in staphylococci.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

beta-lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Antibiotic resistance: lessons for the future

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Infection in the intensive care unit: beta-lactamase-mediated resistance among Enterobacteriaceae and optimal antimicrobial dosing.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Penicillin resistance and autolysis in enterococci

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Beta-lactam-induced bacteriolysis of amino acid-deprived Escherichia coli is dependent on phospholipid synthesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Reduced degradability by lysozyme of staphylococcal cell walls after chloramphenicol treatment.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Inhibition of wall autolysis of staphylococci by sodium polyanethole sulfonate "liquoid"

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effects of mucopolysaccharides on penicillin-induced lysis of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Suppression of penicillin-induced bacteriolysis of staphylococci by some anticoagulants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Reduction of wall degradability of clindamycin-treated staphylococci within macrophages

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Conditions that induce Staphylococcus aureus heat shock proteins also inhibit autolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bacteriolysis is inhibited by hydrogen peroxide and by proteases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Penicillin-binding protein inactivation by human neutrophil myeloperoxidase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Mechanism of action of penicillin: triggering of the pneumococcal autolytic enzyme by inhibitors of cell wall synthesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Lysis and killing of bacteria by lysosomal proteinases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The activity of the pneumococcal autolytic system and the fate of the bacterium during ingestion by rabbit polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Effect of leukocyte hydrolases on bacteria. XV. Inhibition by antibiotics, metabolic inhibitors, and ultraviolet irradiation of the release by leukocyte extracts, trypsin, and lysozyme of lipopolysaccharide from gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Antiendotoxin strategies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Treating patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

The inflammatory balance in human sepsis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Molecular biology for the critical care physician part I: terminology and technology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Molecular biology for the critical care physician. Part II: where are we now?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Animal models of sepsis and shock: a review and lessons learned.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Apoptosis in sepsis: a new target for therapeutic exploration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Cationic peptides from leukocytes might kill bacteria by activating their autolytic enzymes causing bacteriolysis: why are publications proposing this concept never acknowledged?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Immunotherapy of sepsis: flawed concept or faulty implementation?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Procalcitonin as a marker of the systemic inflammatory response to infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Cytokine and cytokine receptor polymorphisms in infectious disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Evaluation of organ failure: we are making progress

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Coagulation inhibitors in sepsis and disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Leukocytes: friend or foe.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Susceptibility to critical illness: reserve, response and therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Neutropenia: clinical implications and modulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Introduction--infection and critical illness: genetic and environmental aspects of susceptibility and resistance.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Clinical expert round table discussion (session 5) at the Margaux Conference on Critical Illness: Outcomes of clinical trials in sepsis: Lessons learned

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

Bactericidal/permeability-increasing protein--lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101101.X

7 January 2021

10.1034/J.1600-0463.2002.1101101.X

Identifiers

DOI

1 reference

31 July 2017

1 reference